Related references
Note: Only part of the references are listed.Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth
Karen McLean et al.
ONCOGENE (2019)
IL-6 mediates platinum -induced enrichment of ovarian cancer stem cells
Yinu Wang et al.
JCI INSIGHT (2018)
Endocrine therapy in epithelial ovarian cancer
Simon P. Langdon et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2017)
Effects of cytokines derived from cancer-associated fibroblasts on androgen synthetic enzymes in estrogen receptor-negative breast carcinoma
Kyoko Kikuchi et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Estrogen receptor a in cancer associated fibroblasts suppresses prostate cancer invasion via reducing CCL5, IL6 and macrophage infiltration in the tumor microenvironment
Chiuan-Ren Yeh et al.
MOLECULAR CANCER (2016)
Clinical Response to Antiestrogen Therapy in Platinum-Resistant Ovarian Cancer Patients and the Role of Tumor Estrogen Receptor Expression Status
Marina Stasenko et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2015)
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
Weiva Sieh et al.
LANCET ONCOLOGY (2013)
IL-6 and leukemia-inhibitory factor are involved in the generation of tumor-associated macrophage: regulation by IFN-γ
Pascale Jeannin et al.
IMMUNOTHERAPY (2011)
Outcomes After Multiple Lines of Chemotherapy for Platinum-Resistant Epithelial Cancers of the Ovary, Peritoneum, and Fallopian Tube
Richard Wyn Griffiths et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2011)
Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production
Karen McLean et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Reciprocal regulation of 17 beta-estradiol, interleukin-6 and interleukin-8 during growth and progression of epithelial ovarian cancer
Jie Yang et al.
CYTOKINE (2009)
Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer
Gabriella Ferrandina et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells
Dorothee Duluc et al.
BLOOD (2007)
Randomized phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer
David G. Mutch et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Share Paper
